コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 .64 vs 0.38 in boys and R2 = 0.72 vs 0.66 in girls).
2 ; 633 [47.8%] were boys and 690 [52.2%] were girls).
3 en at a median age of 16.2 years (48.5% were girls).
4 der, along with a biological parent for each girl.
5 ng amino acids concentration in peripubertal girls.
6 5-point (95% CI: -1.1, 0.1) better scores in girls.
7 tract length and volume are larger in taller girls.
8 s was 11 years (IQR 8-13) and 178 (53%) were girls.
9 ylation in vaginal cells from soy-fed infant girls.
10 es are noninferior after 2 versus 3 doses in girls.
11 ociated with adiposity only among overweight girls.
12 fat or weight gain in overweight adolescent girls.
13 PFOS (p = 0.026) and PFNA (p = 0.043) among girls.
14 overall incidence was similar among boys and girls.
15 to 4.16 for PFNA (95% CI: 1.36, 12.73) among girls.
16 o -1.3 z-scores in boys and -1.5 z-scores in girls.
17 ntially methylated in the brains of boys and girls.
18 in gender equality and in the development of girls.
19 decreased odds of ASD and ID, though not in girls.
20 orders (ASD) are more common among boys than girls.
21 atic difference in survival between boys and girls.
22 r FGV and delayed age at menarche in Chilean girls.
23 n age, 11.7 years +/- 3.7), with 429 (55.2%) girls.
24 nically silent, and may be more common among girls.
25 k of breast cancer, particularly among older girls.
26 ormula-fed girls compared to cow formula-fed girls.
27 was 136 +/- 14 mm, and 45% of subjects were girls.
28 e included 1038 children; of these, 506 were girls.
29 ncluded in the analysis; 641479 (49.3%) were girls.
30 was immunogenic and well tolerated in young girls.
31 were 5- to 30-fold higher than unvaccinated girls.
32 easurements in mid-childhood, but only among girls.
33 ed with KABC-II MPI score for either boys or girls.
34 le consisted of 499 adolescents [263 (51.8%) girls].
35 decreased risks of other causes of death in girls (0.64 [0.53-0.77]), but not in boys (0.99 [0.84-1.
36 bserved in boys (2.39, 1.40-4.09) and not in girls (0.96, 0.50-1.85; Pinteraction = 0.03); the opposi
37 d mean (SD) mBESS score (boys, 1.21 [1.5] vs girls, 0.71 [1.0]; mean difference, 0.50 [95% CI, 0.27-0
38 with the growth spurt, occurring earlier in girls (10.8 years) than in boys (13.0 years) (P < .001).
39 cyberbullying, and 3655 (3% total, 2647 [5%] girls, 1008 [2%] boys) reported both traditional and cyb
41 by the child (severity: boys, 15.1 [9.8] vs girls, 11.8 [9.2]; mean difference, 3.31 [95% CI, 1.60-5
43 llying only, while 406 (<1% total, 276 [<1%] girls, 130 [<1%] boys,) reported only cyberbullying, and
45 re boys had general and central obesity than girls (15.2% vs. 6.9%; 27.4% vs. 11.7%, respectively; bo
46 le range, 8.9-14.6 years]; 1241 boys and 765 girls), 1667 (83.1%) completed the PedsQL-4.0 at all 3 t
48 (SD) total SAC-C score (boys, 23.9 [3.9] vs girls, 24.9 [3.5]; mean difference, -0.92 [95% CI, -1.61
50 ncluded 107 patients (75 boys [70.1%] and 32 girls [29.9%]; median age at AIS, 7.7 years [interquarti
52 Seventy-three patients (47 boys [64%] and 26 girls [35%]; median age, 8 [interquartile range (IQR), 6
54 cohort included 12 860 boys (61.3%) and 8121 girls (38.7%), with a mean (SD) age of 11.0 (3.56) years
55 s (age range, 4-17 years; 4968 boys and 4789 girls), 4 ADHD symptom trajectories were identified: low
57 4 study participants (62 boys [59.6%] and 42 girls [40.4%]; mean (SD) age, 9.9 [1.5] years), the adju
58 ed in the analysis (753 boys [58.0%] and 546 girls [42.0%]; mean [SD] age, 7.3 [5.3] years), 899 (69.
60 , 501 were sampled (268 boys [53.5%] and 233 girls [46.5%]; mean [SD] age, 7.8 [6.6] years), with 10.
62 udy of 540 infants (281 boys [52.0%] and 259 girls [48.0%]; mean [SD] gestational age, 39.2 [1.1] wee
63 eligible children (712 boys [52.0%] and 657 girls [48.0%]; median [interquartile range] age, 12.9 [1
65 d for mobile follow-up (89 boys [43.6%]; 115 girls [56.4%]; mean [SD] age, 4.1 [0.6] years), 112 atte
66 hese adolescents, we excluded 40 549 (10.4%) girls, 56 107 (8.1%) boys, and all 885 without their sex
67 in the AD group and 198 boys (36.1%) and 350 girls (63.9%) in the non-AD group (data on gender identi
68 ntake.Participants were 240 healthy boys and girls (64%), aged 8-15.9 y (mean +/- SD age: 11.8 +/- 1.
69 nts were evaluated: 189 boys (34.2%) and 363 girls (65.8%) in the AD group and 198 boys (36.1%) and 3
70 ified 1 080 368 adolescents (388 937 [36.0%] girls, 690 546 [63.9%] boys, and 885 [0.1%] adolescents
72 by the parent (severity: boys, 11.1 [7.7] vs girls, 9.4 [8.1]; mean difference, 1.63 [95% CI, 0.21-3.
75 [CI], 0.30-0.66; P < 0.001; n = 72), and in girls, a weak association was noted (Pearson's correlati
76 [SD] age, 4.90 [1.36] years; 10 boys and 10 girls), adherence to glasses wearing was successfully mo
77 (tertile groups) were related to changes in girls' adiposity measurements from ages 7 through 15 yea
78 c association was observed for triclosan and girls' adiposity; however, it was due to effect modifica
79 s case-control study included 110 adolescent girls (age range, 13-17 years) who underwent pelvic MR i
82 (2D_M0,6) and months 0 and 12 (2D_M0,12) in girls aged 9-14 years compared with a 3-dose schedule at
84 virus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9-14 years with one including 3 doses (3D) in
87 boys (27 children total); 6-10 y of age: 10 girls and 10 boys (20 children total); and 11-16 y of ag
91 o 17 years living with the index parent (197 girls and 140 boys with a mean [SD] age of 12.4 [2.0] ye
97 children grouped as follows: 0-5 y of age: 6 girls and 21 boys (27 children total); 6-10 y of age: 10
99 0.1] years) and 45 children born at term (22 girls and 23 boys; mean [SD] age at examination, 6.6 [0.
100 Participants included 478 children (234 girls and 241 boys; mean [SD] age, 9.9 [1.9] years]) and
103 0%) boys, vessel tortuosity in 17/98 (17.3%) girls and 32/131 (24.4%) boys, and posterior spoke-like
104 group comprised 114 persons with myopia (81 girls and 33 boys), while the control group comprised 12
105 s were obtained from 52 preterm children (19 girls and 33 boys; mean [SD] age at examination, 6.6 [0.
106 e study, (mean [SD] age, 9.8 [3.1] years; 50 girls and 35 boys) significant variation in telomere len
109 nths) and 8 patients with cblC deficiency (3 girls and 5 boys; age range, 4 months to 15 years) were
110 108 twins included in the final sample (5894 girls and 5214 boys) were a mean age of 11.3 years at th
111 years of age) included in the study (519821 girls and 547922 boys), 638265 received a streptococcal
112 boys: cornea verticillata in 53/101 (52.5%) girls and 55/131 (42.0%) boys, vessel tortuosity in 17/9
113 one ocular sign was found in 55/101 (54.5%) girls and 62/131 (47.3%) boys: cornea verticillata in 53
115 overweight at diagnosis at age 6.7 years in girls and 8.7 years in boys, and obese at diagnosis at a
118 relative to increasing vaccine uptake among girls and assessed the cost-effectiveness of a sex-neutr
121 18, 6, and 11 is possible if 80% coverage in girls and boys is reached and if high vaccine efficacy i
128 ast, BMI z-score rose from -0.15 to -0.01 in girls and from 0.14 to 0.34 in boys, mainly during 1997
130 .89; P = .01); however, typically developing girls and girls with ASD could not be distinguished (P =
131 less efficient than increasing uptake among girls and highly likely to be cost-effective under curre
134 21), but was not significantly associated in girls and urinary thiocyanate concentration was not asso
137 ement with expectant management (control) in girls and women who were pregnant with singletons (singl
138 ually experienced, 13-26-year-old adolescent girls and young women (hereafter women; N = 1180) from 2
140 n [SD] age, 6.20 [2.16] years; 11 boys and 9 girls) and 20 with strabismic or mixed amblyopia (mean [
141 MI z score, 2.0; mean age, 10.4 years; 66.4% girls) and their parent (mean BMI, 31.9; mean age, 42.9
142 subhazard ratio 4.54 [95% CI 3.25-6.36] for girls, and 3.15 [2.73-3.63] for boys) and of drug-relate
143 alcohol-related death (4.71 [3.28-6.76] for girls, and 3.53 [3.04-4.09] for boys) in the next decade
144 alcohol-related injury (4.55 [3.23-6.39] for girls, and 4.51 [3.89-5.24] for boys), and violent injur
145 subhazard ratio 5.11 [95% CI 3.61-7.23] for girls, and 6.20 [5.27-7.30] for boys), drug-related or a
147 13 children aged 5-14 years [seven boys, six girls] and 11 adolescents aged 15-18 years [six boys, fi
148 adolescents aged 15-18 years [six boys, five girls]) and 10 healthy adults (aged 22-36 years [five me
149 4 and age at menarche.A total of 515 Chilean girls are included in the Growth and Obesity Cohort Stud
152 additional 120 million women and adolescent girls become users of modern contraceptives in 69 of the
153 r are "really, really smart." Also at age 6, girls begin to avoid activities said to be for children
157 e in childhood is higher in boys compared to girls, but it remains unclear whether this inequality ch
158 n, birth weight, and breastfeeding duration, girls carrying the 7-repeat allele of the DRD4 gene and
161 Greater differences in composite scores for girls compared with boys-in favour of girls-were associa
162 h in pectin, have been reported.A 7-year-old girl developed barking cough and pruritus approximately
165 CI, 12.3-12.5 years) in non-African American girls (difference, -0.3 years; 95% CI, -0.4 to -0.1 year
166 CI, 11.5-11.6 years) in non-African American girls (difference, -0.6 years; 95% CI, -0.7 to -0.5 year
169 women, as well as the value of investing in girls' education with a view to long-term violence reduc
172 , and subsequent measures of adiposity among girls enrolled in the Breast Cancer and the Environment
174 quartile range, 6-9 years]; 148 boys and 136 girls), exposure to mouse allergen was detected in 441 (
176 re from personal care products in adolescent girls: findings from the HERMOSA Intervention Study.
177 However, the increased risk of suicide in girls following violent injury versus accident-related i
178 es of SV and substance use within adolescent girls' friendship networks are linked to risk for SV int
182 row, increasing cervical screening uptake in girls from ethnic minorities should be encouraged to eli
183 four soy formula-fed and six cow formula-fed girls from the Infant Feeding and Early Development (IFE
188 Asthma is a disease affecting more boys than girls in childhood and more women than men in adulthood.
191 of human papillomavirus (HPV) vaccine among girls in the Dutch immunization program has plateaued at
195 serum isoleucine and leucine in peripubertal girls, independent of BMI, which may serve as a mechanis
201 f the first 150 participants (80 boys and 70 girls, mean age, 7.4 years), tumor samples adequate for
202 0 593 children reviewed, 408272 (48.6%) were girls; mean (SD) age at diagnosis of type 1 diabetes was
203 ents with biopsy-proved NASH (37 boys and 31 girls; mean age, 12.6 years +/- 2.48; age range, 8-17 ye
204 d DTI images of the knee in 151 children, 73 girls (median age, 14.1 years; range, 6.5-17.8 years) an
205 14480 hospitalizations, 6562 (45.3%) were in girls; median (interquartile range) age was 9 (4-14) yea
207 poor-quality studies; studies of prepubertal girls, men, women without the potential for childbearing
210 types 16 and 18, targeted at 12-13-year-old girls, of whom 92.4% were fully vaccinated in 2008-09.
211 patients in the dyads, 68 were boys, and 61 girls; of the 129 parents, 15 were men, and 114 women.
212 oaches were used: 1) number of total boy and girl offspring, 2) sex of the first and second offspring
213 st wealth quartile), whereas in Timor-Leste, girls only outperformed boys when living in households w
215 oth women and men in addition to the current girls-only vaccination program in the Netherlands, using
216 n <35 years old was found at 70% coverage in girls-only vaccination programs (99% vs 83% for total pr
217 d odds of receiving a diagnosis of asthma in girls (OR, 1.37; 95% CI, 0.98-1.91; Pinteraction = .07)
221 +/- 0.0072 for boys and 1.045 +/- 0.0110 for girls; P = .88), number of contrast-enhanced examination
222 exome and genome sequencing of a 19-year-old girl (P7), initially diagnosed with OTCS, revealed a de
224 in boys, but in the opposite direction among girls, particularly for BDE-28 and -47 (AOR=2.58, 95% CI
226 methamphetamine/tobacco- and tobacco-exposed girls, possibly from increased dendritic branching or sp
231 invariant to incidental features: whether a girl pushes a boy or a button and whether we see it in r
233 l 5 explicitly aims to empower all women and girls, reinforcing the need to have a reliable indicator
236 ve to HPV4, the incremental cost per dose in girls should not exceed a median of AUS$35.99 (80% UI 28
237 methamphetamine/tobacco- and tobacco-exposed girls showed persistently lower FA in anterior corona ra
238 ingroup and outgroup members by boys, among girl sOT levels were positively related to allocations m
241 erformance in 8- to 11-y-old boys but not in girls, thereby counteracting existing sex differences.
244 ecome increasingly evident, especially among girls vaccinated before HPV exposure in countries with h
245 95% CI, 10.8-11.1 years) in African American girls vs 11.6 years (95% CI, 11.5-11.6 years) in non-Afr
246 95% CI, 12.0-12.3 years) in African American girls vs 12.4 years (95% CI, 12.3-12.5 years) in non-Afr
249 st cancer-specific distress among adolescent girls was associated with higher self-perceived risk of
252 erable to stress during the prenatal period, girls were more affected by postnatal stress and cumulat
257 he 181 participants screened, 90 (52 [57.8%] girls) were randomized to the intervention (n = 45) or c
258 n <32 weeks and weight <1500 g at birth), 33 girls, were recruited from October 2012 to October 2014
259 es for girls compared with boys-in favour of girls-were associated with higher national Gender Develo
261 elf-harm in the community, whereas for every girl who died by suicide, 1255 attended hospital for sel
263 ions have increased fat intake compared with girls who are noncarriers (DRD4 7+ mean, 33.95% of calor
266 ed drinks were associated with the %FGV with girls who consumed >125 g/d having a %FGV that was 4.5%
267 age, 4.6 mo (95% CI: 1.9, 7.4 mo) later than girls who consumed no yogurt (P-trend = 0.01).More-frequ
271 hy postmenarcheal 13- to 14-y-old overweight girls who had calcium intakes of </=600 mg/d in a 12-mo
273 -18 were not statistically different between girls who received 1, 2, or 3 doses of 4vHPV previously.
274 ed pregnancy declined by more than 25% among girls who were 15 to 17 years of age, women who were coh
275 of a dominant follicle were determined, with girls who were highly suspected of having PCOS compared
277 independently measured these criteria in 50 girls who were suspected of having PCOS to assess reprod
283 01); however, typically developing girls and girls with ASD could not be distinguished (P = .54).
284 he discrete categorization as overweight for girls with BMIs near the overweight cutoff, not to the o
285 spective diet and breast composition and 324 girls with data on prospective diet and age at menarche.
288 ended amounts with dairy foods in adolescent girls with habitually low calcium intakes would decrease
289 ating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding t
294 l subjects were 55 age-matched (+/- 2 years) girls with no clinical hyperandrogenism, oligomenorrhea,
297 o p=0.10), but that was not the case for the girls with scores remaining stable regardless of konzo s
298 ate, thiocyanate, and nitrate, respectively) girls with the highest NIS inhibitor exposure (9.6, 2,34
299 Results: Of the 13 patients (5 boys and 8 girls) with PNs present at birth, all PNs were stable (m
300 Vaccinating 40% of boys along with 60% of girls yielded the same gain in life-years (LYs) as incre
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。